Finance

Beta
Lists
300016:SHE
Beijing Beilu Pharmaceutical Co Ltd
CNÂ¥7.57
-1.82%
(-0.14) 1D
Jun 10, 3:04:13 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300016...
Open
CNÂ¥7.65
High
CNÂ¥7.72
Low
CNÂ¥7.45
Mkt. cap
4.46B
Avg. vol.
15.25M
Volume
9.84M
P/E ratio
33.23
52-wk high
CNÂ¥11.98
52-wk low
CNÂ¥7.45
EPS
CNÂ¥0.23
Shares outstanding
581.69M
No. of employees
1K
Open
CNÂ¥7.65
High
CNÂ¥7.72
Low
CNÂ¥7.45
Mkt. cap
4.46B
Avg. vol.
15.25M
Volume
9.84M
P/E ratio
33.23
52-wk high
CNÂ¥11.98
52-wk low
CNÂ¥7.45
EPS
CNÂ¥0.23
Shares outstanding
581.69M
No. of employees
1K
News stories
From sources across the web
About Beijing Beilu Pharmaceutical Co Ltd
CEO-
Employees1.19K
FoundedSep 5, 1992
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
301.53M
288.48M
332.59M
320.37M
Cost of goods sold
157.55M
160.62M
189.95M
171.34M
Cost of revenue
157.55M
160.62M
189.95M
171.34M
Research and development expenses
17.63M
24.94M
29.43M
15.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
94.32M
84.78M
97.35M
84.08M
Operating expense
117.03M
108.76M
130.35M
98.63M
Total operating expenses
274.58M
269.38M
320.30M
269.97M
Operating income
26.95M
19.10M
12.29M
50.40M
Other non operating income
882.95K
-1.97M
1.55M
-3.19M
EBT including unusual items
14.43M
14.93M
63.53M
54.70M
EBT excluding unusual items
14.39M
14.68M
10.67M
50.52M
Income tax expense
790.19K
2.40M
14.35M
8.54M
Effective tax rate
5.48%
16.10%
22.58%
15.62%
Other operating expenses
1.80M
-820.45K
1.18M
97.64K
Net income
15.43M
14.21M
48.56M
44.98M
Net profit margin
5.12%
4.93%
14.60%
14.04%
Earnings per share
-
-
-
-
Interest and investment income
-
6.81M
2.45M
6.71M
Interest expense
-13.03M
-9.66M
-2.58M
-3.39M
Net interest expenses
-13.03M
-2.85M
-136.14K
3.31M
Depreciation and amortization charges
-
-
-
-
EBITDA
50.48M
41.65M
36.01M
74.12M
Gain or loss from assets sale
1.27M
-1.27M
1.23M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more